PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 13 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $14,367,000 | +0.9% | 51,775,000 | 0.0% | 0.21% | +3.4% |
Q1 2017 | $14,238,000 | +7.8% | 51,775,000 | 0.0% | 0.21% | -11.9% |
Q4 2016 | $13,203,000 | +33.1% | 51,775,000 | +53.3% | 0.24% | +49.7% |
Q3 2016 | $9,921,000 | +23.0% | 33,775,000 | 0.0% | 0.16% | +19.8% |
Q2 2016 | $8,063,000 | – | 33,775,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 22,760,000 | $6,745,000 | 1.39% |
Telemetry Investments, L.L.C. | 9,000,000 | $1,530,000 | 0.69% |
Broadfin Capital, LLC | 15,500,000 | $4,049,000 | 0.49% |
Avoro Capital Advisors LLC | 6,000,000 | $1,651,000 | 0.21% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,775,000 | $14,238,000 | 0.21% |
Aisling Capital LLC | 2,500,000 | $688,000 | 0.12% |
Bruce & Co., Inc. | 2,000,000 | $500,000 | 0.12% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 2,000,000 | $582,000 | 0.06% |
BARINGS LLC | 15,000,000 | $2,550,000 | 0.03% |
ZAZOVE ASSOCIATES LLC | 2,000,000 | $550,000 | 0.03% |